8-55782806-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024831.8(TGS1):c.160A>T(p.Asn54Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000827 in 1,450,896 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024831.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGS1 | NM_024831.8 | c.160A>T | p.Asn54Tyr | missense_variant | 2/13 | ENST00000260129.6 | NP_079107.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGS1 | ENST00000260129.6 | c.160A>T | p.Asn54Tyr | missense_variant | 2/13 | 1 | NM_024831.8 | ENSP00000260129 | P1 | |
TGS1 | ENST00000523948.5 | c.102-2913A>T | intron_variant, NMD_transcript_variant | 1 | ENSP00000430467 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000245 AC: 6AN: 244988Hom.: 0 AF XY: 0.0000227 AC XY: 3AN XY: 132352
GnomAD4 exome AF: 0.00000827 AC: 12AN: 1450896Hom.: 1 Cov.: 27 AF XY: 0.00000970 AC XY: 7AN XY: 721918
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2024 | The c.160A>T (p.N54Y) alteration is located in exon 2 (coding exon 2) of the TGS1 gene. This alteration results from a A to T substitution at nucleotide position 160, causing the asparagine (N) at amino acid position 54 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at